333 related articles for article (PubMed ID: 26086278)
21. Retrospective analysis of spontaneous recovery from neuromuscular blockade produced by empirical use of rocuronium.
Yamamoto H; Uchida T; Yamamoto Y; Ito Y; Makita K
J Anesth; 2011 Dec; 25(6):845-9. PubMed ID: 21935686
[TBL] [Abstract][Full Text] [Related]
22. Rocuronium reversed with sugammadex for thymectomy in myasthenia gravis: A retrospective analysis of complications from Japan.
Tsukada S; Shimizu S; Fushimi K
Eur J Anaesthesiol; 2021 Aug; 38(8):850-855. PubMed ID: 34226417
[TBL] [Abstract][Full Text] [Related]
23. High-dose rocuronium for rapid-sequence induction and reversal with sugammadex in two myasthenic patients.
Casarotti P; Mendola C; Cammarota G; Della Corte F
Acta Anaesthesiol Scand; 2014 Oct; 58(9):1154-8. PubMed ID: 25182127
[TBL] [Abstract][Full Text] [Related]
24. Smoking increases the requirement for rocuronium.
Rautoma P; Svartling N
Can J Anaesth; 1998 Jul; 45(7):651-4. PubMed ID: 9717597
[TBL] [Abstract][Full Text] [Related]
25. Influence of preoperative oral rehydration on arterial plasma rocuronium concentrations and neuromuscular blocking effects: A randomised controlled trial.
Ishigaki S; Ogura T; Kanaya A; Miyake Y; Masui K; Kazama T
Eur J Anaesthesiol; 2017 Jan; 34(1):16-21. PubMed ID: 27606613
[TBL] [Abstract][Full Text] [Related]
26. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
[TBL] [Abstract][Full Text] [Related]
27. Predicting recovery from deep neuromuscular block by rocuronium in children and adults.
Baykara N; Woelfel S; Fine GF; Solak M; Toker K; Brandom BW
J Clin Anesth; 2002 May; 14(3):214-7. PubMed ID: 12031756
[TBL] [Abstract][Full Text] [Related]
28. A clinical study of the effects of rocuronium in isoflurane-anaesthetized cats.
Auer U; Mosing M
Vet Anaesth Analg; 2006 Jul; 33(4):224-8. PubMed ID: 16764586
[TBL] [Abstract][Full Text] [Related]
29. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
30. Anaesthetic management of myasthenia gravis in coronary artery bypass grafting.
Vanjari V; Maybauer MO
Ann Card Anaesth; 2020; 23(2):209-211. PubMed ID: 32275037
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
Kopman AF; Kopman DJ; Ng J; Zank LM
J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial to identify optimal precurarizing dose of rocuronium to avoid precurarization-induced neuromuscular block.
Fukano N; Suzuki T; Ishikawa K; Mizutani H; Saeki S; Ogawa S
J Anesth; 2011 Apr; 25(2):200-4. PubMed ID: 21225293
[TBL] [Abstract][Full Text] [Related]
33. Rocuronium in infants, children and adults during balanced anaesthesia.
Taivainen T; Meretoja OA; Erkola O; Rautoma P; Juvakoski M
Paediatr Anaesth; 1996; 6(4):271-5. PubMed ID: 8827742
[TBL] [Abstract][Full Text] [Related]
34. Fade of train-of-four ratio despite administration of more than 12 mg kg(-1) sugammadex in a myasthenia gravis patient receiving rocuronium.
Kiss G; Lacour A; d'Hollander A
Br J Anaesth; 2013 May; 110(5):854-5. PubMed ID: 23599531
[No Abstract] [Full Text] [Related]
35. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
36. Is the degree of sensitivity to nondepolarizing muscle relaxants related to requirements for postoperative ventilation in patients with myasthenia gravis?
Kadoi Y; Hinohara H; Kunimoto F; Niijima A; Saito S; Goto F
Anaesth Intensive Care; 2004 Jun; 32(3):346-50. PubMed ID: 15264728
[TBL] [Abstract][Full Text] [Related]
37. The effects of age on maintenance of intense neuromuscular block with rocuronium.
Furuya T; Suzuki T; Kashiwai A; Konishi J; Aono M; Hirose N; Kato J; Ogawa S
Acta Anaesthesiol Scand; 2012 Feb; 56(2):236-9. PubMed ID: 22236347
[TBL] [Abstract][Full Text] [Related]
38. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
39. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
Whalley DG; Maurer WG; Knapik AL; Estafanous FG
Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
[TBL] [Abstract][Full Text] [Related]
40. Effects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: A randomised trial.
Rotava P; Cavalcanti IL; Barrucand L; Vane LA; Verçosa N
Eur J Anaesthesiol; 2013 Oct; 30(10):599-604. PubMed ID: 23635996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
